Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
M3-Brigade Acquisition VI Corp.M3-Brigade Acquisition VI Corp. Reports $3.02 Million Net Income in Q2 2026
Rocket One Inc.Rocket One Inc. Reports $3.83 Million Net Loss in Q2 2026, Focuses on AI Infrastructure
CEMTREX INCCemtrex Reports Q3 2026 Revenue of $18.4M, Net Loss of $4.5M
Launch Two Acquisition Corp.Launch Two Acquisition Corp. Reports Decrease in Net Income and Working Capital Deficit
Vivos Therapeutics, Inc.Vivos Therapeutics Reports 35% Revenue Growth to $5.2 Million, Faces Increased Net Loss
CALLAN JMB INC.Callan JMB Inc. Reports Revenue Decline and Increased Net Loss in Q2 2026
BIOXYTRAN, INCBioxytran Reports Significant Financial Losses and Increased Liabilities in Latest 10-Q Filing
Quantumsphere Acquisition CorpQuantumsphere Acquisition Corporation Reports Net Income Turnaround and Merger Plans
ADIAL PHARMACEUTICALS, INC.Adial Pharmaceuticals Reports $54M Net Loss Amid Azora Acquisition
LFTD PARTNERS INC.LFTD Partners Inc. Reports Significant Decline in Q2 2026 Financial Performance
Aspira Women's Health Inc.Aspira Women’s Health Reports 15% Revenue Decline and Net Loss in Q2 2026
BUDA JUICE, INC.Buda Juice Reports 26.4% Revenue Growth to $4.5 Million in Q2 2026
Atlassian CorpAtlassian Reports 26% Revenue Growth to $6.57 Billion in Fiscal Year 2026
VIDA Global Inc.VIDA Global Inc. Reports 344% Revenue Growth in Q2 2026, Despite Net Loss
Replimune Group, Inc.Replimune Reports $69.8 Million Net Loss, Progresses with TUDRIQEV Launch
374Water Inc.374Water Reports 280% Revenue Growth and Reduced Net Loss in Q2 2026
Beeline Holdings, Inc.Beeline Holdings Reports Q2 2026 Financial Results with Improved Revenue and Net Loss
20/20 Biolabs, Inc.20/20 Biolabs Reports 36.5% Revenue Growth in Q2 2026 Despite Increased Net Loss
Processa Pharmaceuticals, Inc.Processa Pharmaceuticals Reports Decreased Net Loss and Strategic Acquisition of Vidya Therapeutics
Cantor Equity Partners VI, Inc.Cantor Equity Partners VI Reports Net Income of $873,841 for Q2 2026 Following IPO
JENA ACQUISITION Corp IIJena Acquisition Corporation II Reports Q2 2026 Net Income of $1.88 Million, Significant Turnaround
Jet.AI Inc.Jet.AI Inc. Reports Revenue Growth and Strategic Shift in Q2 2026 Financial Results
Bryn Inc.Bryn Inc. Reports Increased Operating Expenses and Continued Revenue Absence in Q2 2026
Blue Water Acquisition Corp. IVBlue Water Acquisition Corp. IV Reports Q2 2026 Financial Results with $842,829 Net Income
Origin Investment Corp IOrigin Investment Corp I Reports Q2 2026 Financial Results with Net Income of $384,061